PATENT CLAIM ANALYSIS

Application Number: 15881409
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["435", "006120"]

Abstract:
Provided herein is technology for neoplasia screening, and particularly, but not exclusively, to methods, compositions, and related uses for detecting the presence of cancer, in particular, colorectal cancer.

Claim (Index 101):
The method of  claim 100 , wherein the at least one control nucleic acid comprises a region of a \u03b2-actin gene and/or a region of a B3GALT6 gene.

Metadata:
- Claim Count in Document: 324.0
- Percentile: 86.0
- Lexical Diversity: 1.33333
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15471337', '15841006', '14966938', '15252966', '14669834']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6385890560019757
- 35 USC 102 Novelty (BERT): 0.5416171479965493
- Combined Prediction Score: 0.628891865201433
- Mean Citation Score: 348.420024
- Max Citation Score: 412.8369
- Similarity Product: 262.24030803523067

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test